What is the AIMS65 score?

AIMS65 is a five-item clinical scoring system that predicts inpatient mortality risk in patients presenting with acute upper gastrointestinal bleeding. Each letter represents one criterion: Albumin 1.5, altered Mental status, Systolic BP ≤90 mmHg, and age ≥65 years. The score ranges from 0 to 5.

How do I calculate the AIMS65 score?

Assign one point for each positive criterion: albumin below 3.0 g/dL, INR above 1.5, altered mental status (disorientation/lethargy/stupor/coma), systolic BP at or below 90 mmHg, and age 65 or older. Sum the points. All five variables are available at initial ED presentation without endoscopy.

What does each AIMS65 score mean for prognosis?

Score 0–1: approximately 0.3% inpatient mortality (low risk). Score 2: approximately 0.9–3% (moderate risk). Score 3–5: approximately 7–15% inpatient mortality (high risk). Patients with score ≥3 warrant ICU-level monitoring and urgent endoscopy.

How does AIMS65 differ from Glasgow-Blatchford Score?

AIMS65 is optimized to predict inpatient mortality (AUROC ~0.77). Glasgow-Blatchford Score (GBS) is optimized to predict need for clinical intervention — transfusion, endoscopic hemostasis, or surgery (AUROC ~0.90 for intervention). GBS is preferred for identifying patients who need treatment; AIMS65 is preferred for estimating mortality risk and guiding ICU admission decisions.

Who is considered high risk for UGIB?

High-risk UGIB features include hemodynamic instability (HR >100, SBP <100 mmHg), active hematemesis, hemoglobin <8 g/dL, high GBS (≥12) or AIMS65 (≥2), stigmata of chronic liver disease, coagulopathy, and advanced age. Risk is dynamic — reassess every 2–4 hours in the first 12 hours.

What are the AIMS65 score treatment implications?

Low score (0–1): Standard ward admission, PPI infusion, next-day endoscopy may be appropriate. Moderate score (2): Monitored bed, expedited endoscopy within 12–24 hours, early GI consultation. High score (3–5): Consider ICU admission, aggressive fluid resuscitation, cross-match blood products, urgent endoscopy, early surgical and interventional radiology consultation.

What is inpatient mortality in upper GI bleeding?

Inpatient mortality refers to death occurring during the index hospitalization for UGIB, typically within 30 days. Modern overall UGIB inpatient mortality is approximately 2–5% in unselected populations, but rises to 7–15% in high-risk patients (AIMS65 ≥3, cirrhosis, active bleeding, comorbid organ failure). Causes include rebleeding, multi-organ failure, aspiration pneumonia, and cardiac events.

When should endoscopy be performed for upper GI bleeding?

ACG 2021 guidelines recommend endoscopy within 24 hours for most UGIB patients after hemodynamic resuscitation. In high-risk patients with AIMS65 ≥3, active hematemesis, or hemodynamic instability refractory to resuscitation, early endoscopy within 12 hours may improve outcomes. Endoscopy should not be rushed before adequate resuscitation — hemoglobin and hemodynamics should be partially stabilized first.

When should a patient with GI bleeding be admitted to the ICU?

ICU admission should be considered for UGIB patients with: AIMS65 ≥3, active hematemesis, hemodynamic instability (SBP 100 despite fluids), hemoglobin <7 g/dL requiring urgent transfusion, severe coagulopathy, cirrhosis with decompensation (Child-Pugh C), altered mental status, or need for mechanical ventilation. AIMS65 ≥3 alone justifies strong consideration of ICU-level monitoring.

What are the common causes of upper GI bleeding?

Most common causes: peptic ulcer disease (30–50%), gastroesophageal varices (10–20% in cirrhotic patients), Mallory-Weiss tears (5–15%), erosive gastritis or esophagitis (10%), and less commonly Dieulafoy lesions, vascular ectasia, portal hypertensive gastropathy, or gastric cancer. Endoscopy is required for definitive diagnosis and therapeutic management.

What does low albumin mean in upper GI bleeding?

Albumin <3.0 g/dL in the context of UGIB may reflect: chronic liver disease with impaired synthetic function, malnutrition or frailty, acute severe inflammation (negative acute-phase reactant), capillary leak from systemic illness, or malignancy. All of these conditions increase mortality risk in UGIB independently. Hypoalbuminemia identifies patients with reduced physiologic reserve to withstand the systemic stress of hemorrhage.

How does AIMS65 compare to the Rockall Score?

Rockall Score (post-endoscopy) incorporates endoscopic findings (diagnosis, stigmata of recent hemorrhage) and is the most accurate predictor of rebleeding and post-endoscopy mortality (AUROC 0.81). AIMS65 is calculated pre-endoscopy from clinical variables and predicts inpatient mortality. Both serve complementary roles: AIMS65 for early triage decisions, Rockall for post-endoscopy risk stratification and safe discharge planning.

Online Medical Tools — AIMS65

Printed on 9/2/2026

For informational purposes only. This is not medical advice.

Gastroenterology

AIMS65

AIMS65 is a simple bedside risk score for upper GI bleeding severity. It includes Albumin below 3.0 g/dL, INR above 1.5, altered Mental status, Systolic BP at or below 90 mmHg, and Age 65 years or older.

Formula: AIMS65 = sum of 5 binary criteria (0-5 total).

Albumin < 3.0 g/dL

INR > 1.5

Altered mental status

Systolic BP <= 90 mmHg

Age >= 65 years

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Gather five clinical and laboratory criteria at ED presentation

At initial evaluation of upper GI bleeding, collect five variables available before endoscopy: serum albumin (low if <3.0 g/dL), INR (elevated if >1.5), mental status assessment (altered if disorientation, lethargy, stupor, or coma are present), systolic blood pressure (low if ≤90 mmHg), and patient age (≥65 years). All five variables are obtainable from the initial history, exam, and basic laboratory panel — no endoscopy is required to calculate AIMS65. Document each finding clearly as it arrives.

Sum the binary criteria for a score of 0–5

Each of the five criteria contributes exactly one point if present and zero if absent. Total the positive findings: a score of 0 indicates all five criteria are negative; a score of 5 indicates all are positive. The simplicity of the binary scoring — compared with the continuous variables used in Glasgow-Blatchford — allows rapid bedside calculation without a calculator in most cases.

Interpret score to guide disposition and care intensity

Use the AIMS65 score to estimate inpatient mortality risk and guide resource allocation: Score 0–1 = low mortality risk (~0.3%) — standard ward admission is generally appropriate with urgent endoscopy within 24 hours. Score 2 = moderate risk (~0.9–3%) — consider step-down or monitored ward bed, early attending involvement. Score 3–5 = high mortality risk (7–15%) — ICU-level monitoring should be considered, multidisciplinary involvement (GI, surgery, critical care), aggressive resuscitation, and earliest possible endoscopy (<12 hours in hemodynamically unstable patients). Document score and disposition rationale.

Who Uses the AIMS65

Emergency Department Triage

Emergency physicians

Calculate AIMS65 immediately when a patient presents with hematemesis, coffee-ground emesis, or melena. Use alongside vital signs and hemoglobin to determine care level before GI consultation arrives.

ICU vs Floor Admission Decision

Hospitalists and intensivists

AIMS65 ≥3 identifies patients at 7–15% inpatient mortality — a threshold that justifies ICU admission, continuous monitoring, and early involvement of gastroenterology and surgical teams.

Endoscopy Timing Guidance

Gastroenterologists

High AIMS65 scores support early (urgent, <12 hours) endoscopy in hemodynamically compromised patients, while low scores (0–1) may allow standard next-day endoscopy without compromising outcomes.

Hospital Resource Allocation

Hospital administrators and charge nurses

AIMS65 provides an objective early severity estimate to support ICU bed planning, blood bank activation, and staffing decisions in facilities managing high UGIB volumes.

Comparative Risk Tool Selection

Clinical educators and fellows

Teach the difference between AIMS65 (predicts inpatient mortality), Glasgow-Blatchford Score (predicts intervention/transfusion need), and Rockall Score (post-endoscopy rebleeding and mortality) so that each is applied to the right clinical question.

Quality Improvement Benchmarking

Quality improvement teams

Use AIMS65 as a severity-adjusted benchmark in UGIB outcome audits. Compare observed vs expected mortality across risk strata to identify care gaps and best practices.

Pro Tips

AIMS65 predicts inpatient mortality specifically

Unlike Glasgow-Blatchford Score (which predicts need for intervention or transfusion), AIMS65 was specifically designed and validated for inpatient mortality prediction. Choose your scoring tool based on the clinical question: GBS for 'does this patient need something done?', AIMS65 for 'how likely is this patient to die?'

AIMS65 is simpler than GBS — no heart rate or comorbidity scoring required

Glasgow-Blatchford incorporates heart rate, BUN thresholds, hemoglobin, syncope, hepatic disease, and cardiac failure. AIMS65 uses only five binary yes/no criteria all available from the initial basic assessment. This makes AIMS65 faster to calculate at the bedside in a busy emergency department.

All five variables are pre-endoscopy — no procedure needed

AIMS65 can be calculated immediately from history, physical exam, and initial laboratory results. This is a key advantage over the Rockall Score, which requires endoscopic findings (diagnosis and stigmata of recent hemorrhage) and therefore cannot be completed at initial triage.

GBS is better for predicting intervention; AIMS65 better for predicting mortality

Head-to-head comparisons (Hyett et al. 2013, multiple meta-analyses) show AIMS65 outperforms GBS for inpatient mortality (AUROC ~0.77 vs ~0.72), while GBS outperforms AIMS65 for predicting blood transfusion need and endoscopic intervention. Use both for complete risk stratification.

Rockall Score best used POST-endoscopy

Rockall Score incorporates endoscopic diagnosis and stigmata of recent hemorrhage, making it the superior tool for post-endoscopy rebleeding prediction. Reserve Rockall for after endoscopy; use AIMS65 and GBS at triage.

Altered mental status definition: more than just confusion

In AIMS65, 'altered mental status' = disorientation, lethargy, stupor, or coma — not simply mild agitation or anxiety. Critically, this criterion is often missed in elderly patients with baseline dementia. Document the patient's baseline cognitive status and compare to the current exam.

INR >1.5 is common in cirrhotic patients — scores independently of bleed severity

Cirrhotic patients often have baseline INR >1.5 due to impaired hepatic synthesis of coagulation factors, even without active coagulopathy from the bleed itself. This means AIMS65 may systematically score higher in cirrhotic patients — incorporate Child-Pugh and MELD score for full hepatic reserve assessment.

Low albumin is a powerful marker of chronic illness or acute severity

Albumin <3.0 g/dL reflects either chronic nutritional depletion/liver disease or acute severe illness (acute-phase response, capillary leak). Its presence in AIMS65 captures both background frailty and acute severity — either way it predicts worse outcomes in UGIB.

Combined AIMS65 + GBS provides the most complete pre-endoscopy risk stratification

ACG and ASGE guidelines acknowledge both scores' complementary roles. Clinically, a patient with AIMS65 ≥2 AND GBS ≥12 represents high-risk for both mortality and intervention need — this combination should trigger immediate GI consultation, ICU consideration, and early endoscopy (<12 hours).

Early endoscopy (<24 hours) improves outcomes in high-risk UGIB

Multiple RCTs and meta-analyses confirm that endoscopy within 24 hours reduces length of stay and rebleeding risk in high-risk UGIB. In hemodynamically unstable patients or those with AIMS65 ≥3, very early endoscopy (<12 hours) after resuscitation is supported by current ACG guidelines (2021).

Common Questions About Your Results

AIMS65 predicts inpatient mortality in UGIB (AUROC ~0.77). Glasgow-Blatchford Score predicts the need for clinical intervention — blood transfusion, endoscopic hemostasis, or surgery — and is better validated for this endpoint (AUROC ~0.90). Both should ideally be calculated at triage: GBS guides the 'does this patient need something?' decision, AIMS65 guides the 'how severely ill is this patient?' question.

In AIMS65 scoring, INR >1.5 scores one point regardless of cause — whether from warfarin/anticoagulant therapy, hepatic synthetic dysfunction, or coagulopathy from acute hemorrhage. However, the clinical interpretation differs: anticoagulant-related INR elevation does not represent the same degree of coagulopathy severity as hepatic failure-related elevation. Note this distinction when communicating prognostic estimates.

Document the patient's baseline cognitive status from family, caregivers, or prior records. 'Altered mental status' for AIMS65 scoring requires a change from baseline — new disorientation, lethargy, stupor, or coma. A patient who is chronically disoriented at baseline who presents at their baseline cognitive level should not be scored as altered. When baseline is uncertain, err toward scoring as altered given the safety implications.

Clinical assessment always takes precedence over any single score. An AIMS65 of 2 represents ~0.9–3% inpatient mortality — roughly a 10x increase over score 0–1. Use this to justify closer monitoring, early attending notification, and preparation for potential deterioration. The score identifies risk, not inevitability. Combine with dynamic assessment: if hemodynamics worsen or hemoglobin drops rapidly, escalate regardless of score.

Evidence-Based Methodology

AIMS65 was developed by Saltzman et al. (Gastrointest Endosc 2011) from 29,222 UGIB patients across 187 US hospitals. Score ≥2 had 15x higher mortality than score 0–1. Prospective validation by Hyett et al. (Gastroenterology 2013) confirmed superiority over GBS for inpatient mortality prediction. A 2014 meta-analysis confirmed AIMS65 AUROC ~0.77 for inpatient mortality vs ~0.72 for GBS. ACG UGIB Clinical Guideline (Laine et al., Am J Gastroenterol 2021) references both AIMS65 and GBS for pre-endoscopy risk stratification.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Higher AIMS65 totals indicate greater short-term mortality risk in upper gastrointestinal bleeding.

When to Use This Tool

Use AIMS65 at initial evaluation of suspected upper GI bleeding to support triage, monitoring intensity, and early disposition planning.

Limitations

AIMS65 is a prognostic aid and does not replace clinical judgment or therapeutic endoscopy planning. Performance can vary across populations and care settings.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools